Confluence

Dr. Purnendu Chatterjee is the Founder and Chairman of The Chatterjee Group (TCG), one of the most distinctive cross-sector investment platforms operating today, with portfolios spanning emerging technology, energy, real estate, and life sciences across the United States, India, and Europe.

Over four decades, Dr. Chatterjee has deployed patient capital into industries at inflection points — often before they’re recognized as such. TCG’s portfolio has included foundational positions in petrochemicals, telecom, pharmaceuticals, and frontier technology, built on an investment philosophy rooted in long-duration thinking and structural conviction.

At Confluence Capital, Dr. Chatterjee brings a generational perspective on what it means to allocate capital across borders and across cycles — and on how the convergence of AI, biotech, and aligned capital may shape the decade ahead.

Sonjoy Chatterjee is the Chairman of Goldman Sachs in India, where for over a decade he has led one of the firm’s most strategically consequential markets. Under his stewardship, Goldman’s India platform has scaled across investment banking, asset management, and securities — becoming a central conduit for global capital entering the country.

Before Goldman, Sonjoy spent more than a decade at ICICI Bank, where he held senior leadership roles spanning corporate banking and global markets, giving him a rare dual fluency in the perspectives of Indian institutions and international allocators. He holds degrees from IIT Kharagpur and IIM Ahmedabad.

At Confluence Capital, Sonjoy joins the keynote stage to discuss what global allocators are now learning about India and the broader emerging-market opportunity set, and how the next decade of cross-border deal flow will be shaped by AI, healthcare innovation, and the realignment of global supply chains.

Barun Das is the Managing Director and Chief Executive Officer of TV9 Network, India’s largest broadcast news network — a position from which he has rebuilt one of the country’s most consequential media platforms around a digital-first, multilingual, multi-format thesis. Under his leadership since 2019, TV9 has become the most-watched news network in India, with leadership positions in Telugu, Kannada, Marathi, Gujarati, and Hindi, and a digital footprint that scaled in record time to levels legacy media took two decades to reach.

An alumnus of IIT Madras, IIM Calcutta, and the London School of Economics, Das previously served as the youngest-ever CEO of a major Indian news network at Zee News, with earlier executive roles at India Today Group, MCCS (Star News), ABP Group, and Astro All Asia Networks in Kuala Lumpur. Between his Zee and TV9 stints, he founded Mydia100 Communications, a mobile-video platform at the convergence of technology, content, and healthcare — later acquired by TV9 Network.

At TV9, Das has launched two industry firsts that define the company’s tech-forward posture: News9 Plus, India’s first OTT news platform, and Money9, the country’s first multilingual personal finance platform. His long-form interview series Duologue with Barun Das has become a distinctive format in Indian media. At Confluence Vertical, Das brings the perspective of a digital-native media operator who has rebuilt a legacy industry around platforms, languages, and audiences — and a sharp view of how AI, OTT, and personalized content are reshaping the global media economy.

Dr. Asoke Deysarkar is a deep-tech operator and Ph.D. chemical engineer who has built one of the most patented industrial-chemistry platforms in the United States. As founder and Chairman & CEO of PfP Industries, he leads a Houston-based holding of five operating companies producing the specialty chemistries — polyacrylamide friction reducers, guar polymers, and proprietary stimulation systems — that power modern oilfield completions across North America.

What started as a single product line has scaled into a vertically integrated platform: a guar manufacturing facility in India, distribution and blending sites across Texas, Wyoming, Montana, and Ohio, an in-house R&D lab, and a patent portfolio spanning fluid rheology, friction reduction, and water treatment. Recognized as a Top 100 Company in Houston, PfP exemplifies the kind of deep-tech industrial operator the modern capital market is rediscovering: science-led, patent-rich, hard to disrupt.

Alongside his operating role, Dr. Deysarkar is an active angel investor and advisor to a portfolio of early- and growth-stage companies, drawing on decades as a builder to back founders working in hard tech, industrial AI, and the science-led category leaders being built today. At Confluence Capital, he brings the dual perspective of a founder-CEO who has compounded an industrial company across three energy cycles and an investor now allocating capital and conviction behind the builders shaping what comes next.

Ro Khanna represents California’s 17th Congressional District, which covers much of Silicon Valley — home to many of the technology companies shaping the global economy. First elected to the U.S. House of Representatives in 2016 and serving since January 2017, he has built a national profile at the intersection of technology policy, economic opportunity, and the role of government in an era of rapid technological change.

A graduate of the University of Chicago, where he earned a degree in economics, and Yale Law School, Khanna worked as an attorney and law professor before entering Congress, and earlier served as a deputy assistant secretary at the U.S. Department of Commerce. He is the author of Dignity in a Digital Age: Making Tech Work for All of Us, which argues for distributing the gains of the technology economy more broadly across the country. His legislative work has spanned digital infrastructure, civil liberties, economic policy, and congressional authority over matters of war and peace.

At Confluence 2027, Congressman Khanna brings the perspective of a policymaker who represents the center of the technology economy — offering a view on how AI, capital, and innovation intersect with public policy, and on the responsibilities that come with building the technologies that increasingly shape everyday life.

Dr. Achintya Moulick is a cardiothoracic surgeon, healthcare CEO, and one of the few clinicians in the world equally trained in adult cardiac and complex neonatal heart surgery. He serves as President and Chief Executive Officer of CarePoint Health (Hudson Health System), a New Jersey–based integrated health system, and is the Founder and Chair of the Global Health Forum (GHF) — a cross-continental think tank uniting leaders from medicine, technology, policy, and industry to design more equitable, more accessible healthcare systems.

A pioneer of surgical ventricular restoration and holder of an MBA in Finance and Healthcare from George Washington University, Dr. Moulick was the founding cardiac surgeon at India’s Fortis Heart Institute and went on to lead some of the most demanding programs in American cardiac medicine — at UCLA, Children’s National in Washington, D.C., and St. Christopher’s Hospital for Children in Philadelphia — before moving into hospital-system leadership.

Through GHF, Dr. Moulick has built a working platform for the next generation of healthcare innovators: a global accelerator network and Venture Forum that mentors and seed-funds physician-entrepreneurs and healthcare startups across the U.S., India, Europe, and Latin America. The inaugural Global Health Congress, held at the Yale Club of New York in November 2025, convened leaders from over twenty countries on AI in clinical practice, longevity, hospital innovation, and Indo–U.S. collaboration. At Confluence Vital, Dr. Moulick brings the rare perspective of a working surgeon, operating CEO, and platform founder building the bridge between medicine, technology, capital, and policy.

Dr. Annu Navani is a clinician-entrepreneur whose work spans pain medicine, regenerative therapies, and clinical innovation. She is the founder of Boomerang Healthcare, a California-based clinical group specializing in interventional pain medicine and regenerative care; Le Rêve Regenerative Wellness Center, delivering regenerative therapies alongside longevity protocols and aesthetic care; and the World Institute of Regenerative Medicine (WIRM), the global platform she chairs, uniting clinicians, scientists, investors, and industry leaders advancing regenerative, precision, and longevity medicine.

Across these platforms, Dr. Navani has built her practice around an integrative model — combining diagnostic precision with image-guided interventions and regenerative approaches — to treat patients for whom conventional pain management has fallen short. She has also been an active voice in the broader conversation around the future of pain care, the science of regenerative medicine, and the evolving role of clinician-entrepreneurs in healthcare delivery.

At Confluence Vital, Dr. Navani brings a frontline operator’s perspective on where regenerative medicine actually delivers for patients today, where it is still aspirational, and what the convergence of AI, diagnostics, and biologics may unlock next.

Rahul Roy is a Silicon Valley entrepreneur whose career spans more than three decades of founding, building, and scaling enterprise software companies. He serves as Chief Technology Officer of ARC Document Solutions, a cloud SaaS company anchoring the architecture, engineering, and construction (AEC) industry — North America’s largest specialized document-solutions provider.

Alongside his operating role, Roy is an active angel investor and advisor to a portfolio of early- and growth-stage technology companies, lending capital, technical depth, and operator perspective to founders across the Valley. His track record as a builder — including leadership roles — informs an advisory practice grounded in what it actually takes to ship product and scale a company.

Roy is also Chairman of the ROY Foundation — a Confluence 2027 founding partner — dedicated to helping underprivileged children in India access education and opportunity. A patron of arts and cultural heritage and a frequent voice on technology, entrepreneurship, and the role of the Indian diaspora in American innovation, he brings to Confluence Vertical a long-view operator’s perspective on building technology companies that endure across cycles.

Suvankar Sen is the Whole Time Director, Managing Director, and Chief Executive Officer of Senco Gold — one of India’s largest organized jewellery retailers and a publicly listed company with over 160 showrooms across India and the diaspora.

He serves as a Committee and Board member of the Gems & Jewellery Export Promotion Council, the ICC Gems & Jewellery panel, and the ASSOCHEM bullion and jewellery council — shaping the policy, standards, and export strategy of one of India’s most globally significant industries. He additionally holds directorships across Senco Gold Artisanship, Senco Global Jewellery Trading LLC (Dubai), Sennes Fashion, and the broader Senco group of companies.

At Confluence Capital, Suvankar brings a generational perspective on what it takes to scale a heritage brand from a regional craft to a national category leader — and on the role Indian organized retail plays in connecting tradition, design, and global capital.

Vishal Tripathi is a Silicon Valley venture investor focused on the next generation of frontier technology and the operators building it. He serves as Vice President of Investment at Olive Partners Management, a Menlo Park–based investment firm, where he leads diligence and portfolio construction across venture and growth-stage opportunities.

Before Olive Partners, Tripathi spent five years at the intersection of venture capital and impact investing — first as a Portfolio Manager at Plexo Capital, then at Legacy Venture and Next Legacy Partners, the venture fund-of-funds platform that amplifies the venture access of philanthropists, athletes, cultural luminaries, and founders. He began his career in quantitative research at J.P. Morgan before pivoting full-time into venture capital.

At Confluence Capital, he brings the perspective of an institutional investor allocating capital across the very ecosystem the conference convenes — surfacing what’s getting funded, where the bar has moved, and how founders can engage the capital actually deploying in 2027.